This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The Canadian Securities Exchange Composite Index dropped 6.85 points to 424.45 Tuesday. Medmen Enterprises Inc. (MMEN) sank 42 cents to $1.38 on 2.71 million shares following the release of its fiscal 2019 results after the market closed yesterday. The United States-based cannabis retailer recorded a colossal $277-million (U.S.) loss in the year. The company's losses are well-documented, but they are worth revisiting. Medmen lost $194-million (U.S.) in the first three quarters of its fiscal 2019. The company acknowledged long ago that its excessive spending was a problem. In February, 2019, Medmen warned, "At our current operating level, we will not have sufficient funds generated from operations to cover our short-term and long-term operational needs." Yet, in fiscal Q4, the company still posted an $82.9-million (U.S.) loss.

There are plenty of areas that Medmen should be able to cut back. A quick look into the company's general and administrative expenses reveals that Medmen spent $14.4-million (U.S.) on security and $7.7-million (U.S.) on travel and entertainment. The high times and excessive spending has contributed to the company's decline to $1.38 from its high of $9.88, which it touched last October.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS